Loading organizations...
Loading organizations...
Biopharmaceutical company developing novel Alphabodies™ therapies.
Complix has raised $25.1M across 4 funding rounds.
Complix has raised $25.1M in total across 4 funding rounds.
Complix has raised $25.1M in total across 4 funding rounds.
Complix's investors include Flemish government, Biotech Fund Flanders, Patrick Van Beneden, Baekeland II Fund, CRP-Sant, Gemma Frisius Fund, LRM, Omnes Capital, TrustCapital, Vesalius Biocapital, Vinnof, Emmanuelle Coutanceau.
Complix has raised $25.1M across 4 funding rounds. Most recently, it raised $590K Grant in December 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 14, 2017 | $590K Grant | Flemish government | |
| Jun 26, 2013 | $15.6M Series B | Biotech Fund Flanders, Patrick Van Beneden | Baekeland II Fund, CRP-Sant, Gemma Frisius Fund, LRM, Omnes Capital, TrustCapital, Vesalius Biocapital, Vinnof |
| Feb 2, 2011 | $2.8M Series A Extension | Emmanuelle Coutanceau | |
| Jun 14, 2010 | $6.1M Series A | LRM, Vesalius Biocapital | CRP-Sant |